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The potential of acetylsalicylic 
acid and vitamin E in modulating 
inflammatory cascades in chickens 
under lipopolysaccharide-induced inflammation
Paweł Konieczka1,2* , Marcin Barszcz1, Paweł Kowalczyk1, Michał Szlis1 and Jan Jankowski2
Abstract 
Distinct enzymes, including cyclooxygenase 1 and 2 (COX-1 and COX-2), lipoxygenase (LOXs), and cytochrome P450 
monooxygenase (CYP450), produce different stress mediators and mediate inflammation in birds. Bioactive agents 
such as acetylsalicylic acid (ASA) and vitamin E (vE) may affect enzyme activities and could be used in poultry produc-
tion to control the magnitude of acute phase inflammation. Here, we characterized COX, LOX, and CYP450 mRNA 
expression levels in chicken immune tissues in response to Escherichia coli lipopolysaccharide (LPS) challenge and 
investigated whether ASA and vE could alter gene expression. Additionally, for the first time in chickens, we evaluated 
oxygen consumption by platelet mitochondria as a biomarker of mitochondria function in response to ASA- and vE. 
LPS challenge compromised bird growth rates, but neither dietary ASA nor vE significantly ameliorated this effect; 
however, gradually increasing dietary vE levels were more effective than basal levels. ASA regulated arachidonic 
acid metabolism, providing an eicosanoid synthesis substrate, whereas gradually increasing vE levels evoked aspirin 
resistance during challenge. Gene expression in immune tissues was highly variable, indicating a complex regulatory 
network controlling inflammatory pathways. However, unlike COX-1, COX-2 and CYP450 exhibited increased mRNA 
expression in some cases, suggesting an initiation of novel anti-inflammatory and pro-resolving signals during chal-
lenge. Measuring oxygen consumption rate, we revealed that neither the ASA nor vE levels applied here exerted toxic 
effects on platelet mitochondria.
© The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Modern-day broilers achieve market weight at an age 
when their immune system is not fully developed; thus, 
it is a great challenge for fast-growing birds to cope with 
pathophysiological disorders during infectious disease. In 
poultry, physiological and pathological stimuli, includ-
ing pathogen invasion, trigger activation of the arachi-
donic acid (AA, 20:4n-6) metabolic cascade, which is 
controlled by three enzymatic pathways: cyclooxygenase 
1 and 2 (COX-1 and COX-2, respectively), lipoxygenase 
(LOXs), and cytochrome P450 monooxygenase (CYP450) 
pathways. The activity of the respective enzymes results 
in the formation of eicosanoids, which are locally acting 
lipid mediators of inflammation and tissue homeostasis. 
The COX-derived eicosanoids are prostaglandins (PGs) 
and thromboxanes (TXs), the LOX-derived eicosanoids 
are leukotrienes (LTs), and the CYP450-derived eicosa-
noids are hydroxyeicosatetraenoic acids (HETEs) and 
epoxyeicosatrienoic acids (EETs). The biosynthesis of 
eicosanoids is considerably increased in various challeng-
ing conditions, and their specific conversion to biologi-
cally active products determines the magnitude, duration 
and nature of subsequent pain perception or inflamma-
tory responses [1].
The recognition of microbial components, such 
as lipopolysaccharide (LPS), by pattern recogni-
tion receptors, constitutes a first-line defence against 
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invading pathogens in birds. Consequently, pathogen 
stimulation triggers the induction of various signal-
ling pathways, including releasing AA from membrane 
phospholipids of antigen-presenting cells by the action 
of phospholipase  A2 and converting released AA into 
different groups of eicosanoids [2]. In general, AA-
derived eicosanoids act as proinflammatory molecules 
with pain, fever and acute inflammation manifesta-
tions in response to microbial invasion [3]. Given the 
key role of eicosanoids in the innate response of the 
host to pathogen challenge, targeting their regulation 
requires understanding of their complex interactions 
to develop applicable solutions to avian infection prob-
lems [4].
The eicosanoid formation pathway might be affected 
by dietary lipid manipulations. Elevated levels of die-
tary n-3 PUFA supported with vitamin E (vE) as an 
antioxidant exert regulatory actions on the defence 
system by changing AA metabolism, thereby reducing 
damage caused to different cell systems by pathogen 
invasion [5–10]. Another way to target AA-derived 
eicosanoid biosynthesis during inflammation is the 
application of non-steroidal anti-inflammatory drugs 
(NSAIDs), with acetylsalicylic acid (aspirin, ASA) 
being the most frequently used NSAID in poultry. 
The regulatory mechanism of ASA is based on the 
inhibition of the biosynthesis of the most proinflam-
matory PGs via acetylation of COX-1; thus, ASA can 
be used to relieve the acute phase during inflamma-
tion [1]. More recently, the regulatory actions of ASA 
have been reported to be more complex and may affect 
microinflammation through the generation of a novel 
array of bioactive lipid mediators via sets of enzyme-
dependent pathways other than COX-1. Nevertheless, 
among reports, the advances that continue to emerge 
primarily relate to human medicine, while data con-
cerning novel mechanisms targeting avian disease 
problems are scarce.
There is an urgent need in the poultry sector to 
develop an effective strategy that can limit or prevent 
infection using dietary intervention. Given that, in this 
study, we identified the simultaneous actions of COX-, 
LOX-, and CYP450-enzyme sets mediating the inflam-
matory response in birds during E. coli endotoxin chal-
lenge. Additionally, we applied for the first time in a 
chicken model a fluorescence-based analysis of oxygen 
consumption for the direct determination of platelet 
mitochondria function. This method was previously 
applied for use in clinical settings and with a wide 
range of in  vitro models for drug-toxicity assessment 
[11, 12]. In our opinion, this assay may also have the 
potential to be used in inflammation-related studies 
on poultry.
Materials and methods
Chicken experiment
The experiment was run on a total of 108 1-day-old 
female Ross 308 broilers purchased from a local commer-
cial hatchery. The birds were housed in individual cages 
with free access to pelleted feed and drinking water, and 
each bird was fed individually and was considered to be 
a replication. The conditions of the room were main-
tained according to standard management practices in a 
commercial chicken house. The birds were fed diets for-
mulated to meet or exceed their nutritional requirement 
specifications at respective ages [13]. The chickens were 
divided into six dietary treatments. There was a control 
group (birds fed a standard commercial diet with a basal 
vE level—80  mg/kg of diet; placebo). The second treat-
ment (LPS) was the same as the previous one, but the 
birds were challenged with E. coli endotoxin, whereas 
the third treatment (LPS + ASA) was additionally supple-
mented with ASA (1 g/kg of diet). Treatments four, five, 
and six differed from the respective placebo, LPS, and 
LPS + ASA treatments by applying a gradually increasing 
level of vE; 160 and 240 mg/kg of diet fed in the periods 
of 8–21 days and 22–35 days, respectively (Table 1). The 
birds were reared in the individual cages until day 35 of 
age. Feed intake was measured, and body weight gain 
(BWG) was calculated for individual birds.
All experimental procedures in this study were 
approved by the Third Local Animal Experimentation 
Ethics Committee at the Warsaw University of Life Sci-
ences-SGGW, Poland (resolution no. WAW2/60/2017) 
and were in accordance with the principles of the Euro-
pean Union and Polish law on animal protection.
Experimental procedures
LPS challenge
At 32 days of age, each bird was weighed after 4 h of feed 
deprivation (this period of feed withdrawal was used 
Table 1 Experimental design of the chicken experiment 
LPS—birds at 32 days of age were intraperitoneally injected at a dose of 250 μg/
kg of body weight with E. coli LPS; ASA—acetylsalicylic acid at a dose of 1 g/
kg of diet; basal vitamin E (vE) level—80 mg/kg of diet; gradually increasing vE 
level—160 and 240 mg/kg of diet fed in the period 8–21 days and 22–35 days, 
respectively.
Treatments Vitamin E level LPS challenge Acetylsalicylic 
acid
Placebo Basal – –
LPS Basal + –
LPS + ASA Basal + +
Placebo Gradually increasing – –
LPS Gradually increasing + –
LPS + ASA Gradually increasing + +
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before each weighing in this study). During the subse-
quent 3 days, at the same time period, birds of the LPS-
challenged groups were intraperitoneally injected (the 
lower abdominal region) at a dose of 250 μg/kg of body 
weight either with LPS (Escherichia coli serotype O55:B5; 
Sigma Chemical, St. Louis, MO, USA) reconstituted in 
0.9% sterile saline (0.5 mg/mL) or the same dose of ster-
ile saline alone (placebo group). At the end of the evalu-
ation period, birds were weighed, and the individual 
performance indices were calculated for the period of 
LPS challenge.
Quantitative real‑time polymerase chain reaction
At 35  days of age, chickens were sacrificed by cervical 
dislocation, and the abdominal cavity was opened for 
immune tissue sampling (thymus, spleen and bursa of 
Fabricius); immune tissues were frozen immediately after 
collection in liquid nitrogen and then stored in pyrogen-
free test tubes at −80 °C until RNA isolation.
Total RNA from the collected tissues was isolated using 
a Total RNA Mini kit (A&A Biotechnology, Gdynia, 
Poland) according to the manufacturer’s protocol. The 
isolated RNA yield was estimated spectrophotometrically 
(Nanodrop, NanoDrop Technologies, Wilmington, DE), 
with integrity assessed electrophoretically by separation 
on a 1.5% agarose gel containing ethidium bromide. For 
complementary cDNA synthesis, 1500 ng/mL RNA from 
the selected tissues in a total volume of 20 µL was reverse 
transcribed using a TranScriba Kit (A&A Biotechnol-
ogy, Gdynia, Poland) according to the manufacturer’s 
instructions. Specific primers for chicken (Gallus gal-
lus) were designed using Primer 3 software (The White-
head Institute, Cambridge, MA, USA) and synthesized 
by Genomed (Warsaw, Poland). The respective primer 
sequences are shown in Table 2.
Real-time qPCR was conducted using a 5× FIREPol 
EvaGreen qPCR Mix Plus (no ROX; Solis BioDyne, Tartu, 
Estonia) in a total volume of 15  µL containing 3  µL of 
Master Mix, 9 µL of RNase-free  H2O, 2× 0.5 µL of prim-
ers (0.5 mM), and 2 µL of cDNA template. Amplification 
was performed using a Rotor Gene 6000 thermocycler 
(Corbett Research, Mortlake, Australia) according to the 
following protocol: one cycle at 95 °C for 15 min (enzyme 
activation), followed by a PCR including 35 cycles at 
95  °C for 5  s (denaturation), 60  °C for 25  s (annealing), 
and 72  °C for 15  s (elongation), and then one cycle at 
72  °C for 7 min (product stabilization). A melting curve 
was performed over 70–95  °C at 0.5  °C intervals. Nega-
tive controls without the cDNA template were included 
in each reaction. Real-time qPCR for each cDNA sample 
was performed in duplicate. The identity of PCR prod-
ucts was confirmed by direct sequencing (Genomed, 
Warsaw, Poland, data not shown).
Relative gene expression was calculated using the com-
parative quantitation option of Rotor Gene 6000 software 
1.7 (Qiagen GmbH, Hilden, Germany) and determined 
using the Relative Expression Software Tool (2008) 
according to Pfaffl et al. [14], based on a PCR efficiency 
correction algorithm developed by Pfaffl et  al. [15]. The 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), 
β-actin (ACTB) and peptidylprolyl isomerase C (PPIC) 
genes were tested as housekeeping genes, and using Best-
Keeper software, ACTB was chosen as the best endog-
enous control gene to normalize gene expression in this 
study.
Enzyme‑linked immunosorbent assay
Quantitative determinations of AA and 11-dehydro-
thromboxane  B2  (TBX2) in chicken serum were per-
formed spectrophotometrically on a MAXMAT PL 
multidisciplinary diagnostic platform (Erba Diagnostics 
Table 2 Genes and primers used in this study 
ACTB: β-actin, COX-1: cyclooxygenase-1, COX-2: cyclooxygenase-2, LOX-12: lipoxygenase-12, and CYP450p: cytochrome P450.
Gene Primer Sequence (5′–3′) Melting temperature 
(°C)
Product size (nt) GenBank access no.
ACTB Forward TGT TAC CAA CAC CCA CAC CC 60.11 110 NM 205518.1
Reverse TCC TGA GTC AAG CGC CAA AA 60.18
COX-1 Forward GCG CAT CAG TAG ACC TAG CC 60.32 121 JX160009.1
Reverse TGG TAT TGT GAC AGT GCG GG 60.32
COX-2 Forward TGT CCT TTC ACT GCT TTC CAT 57.77 84 NM_001167718
Reverse TTC CAT TGC TGT GTT TGA GGT 58.11
LOX-12 Forward CTG ATT ACG CCG TGC TGG AT 60.53 73 XM_015274997.1
Reverse ATT GGG GCA CAC AGG AAT GT 59.89
CYP450p Forward ACC ACT TCT GGA AGG AGG GA 59.81 108 D49803.1
Reverse CGC TCT CGT AGA CAC CCA AC 60.46
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France SARL, Montpellier, France) using respective 
enzyme-linked immunosorbent assay (ELISA) kits 
(MyBioSource, San Diego, CA, USA) according to the 
manufacturer’s protocols. Briefly, 12 h post-last challenge 
at 34  days of life, blood samples were collected from 9 
chickens into heparinized test tubes, and serum was sep-
arated by centrifugation at 1000 ×  g for 15  min at 2  °C 
within 30 min of collection. Subsequently, serum samples 
were frozen at −80  °C until analysis. Each sample was 
determined in duplicate, and a standard curve was plot-
ted separately for each ELISA plate.
Oxygen consumption assay
Whole blood from 9 chickens from each experimental 
group was collected in an amount of 2 mL into heparin-
ized tubes. Blood was gently mixed to avoid microsphere 
formation, which could reduce the number of platelets 
and impair the results, and placed on ice for 2 h to allow 
sedimentation of individual blood cells. After establish-
ing a visible phase boundary, approximately 150 μL of the 
upper layer containing the platelets were collected and 
transferred to new tubes containing 300  μL of 10  mM 
dimethyl sulfoxide (DMSO) for cryopreservation. Sam-
ples were stored at −20 °C for further analysis. Before the 
analysis, fixed platelets were centrifuged at 3500 × g for 
5  min at 2  °C to remove DMSO. Isolated platelets were 
dissolved in 300 μL of HEPES-buffered Tyrode’s solution 
(119 mM NaCl, 5 mM KCl, 25 mM HEPES buffer, 2 mM 
 CaCl2, 2  mM  MgCl2, and 6  g/L glucose, adjusted with 
NaOH to a final pH of 7.4). Measurement of the extracel-
lular oxygen consumption rate by platelet mitochondria 
was performed on a filter-based multi-mode microplate 
reader (FLUOstar OPTIMA, BMG Labtech, Offenburg, 
Germany) using MitoXpress-Xtra HS kits (Luxcel Com-
pany, Cork, Ireland) according to the manufacturer’s 
protocol. Fluorescence intensity measurement was per-
formed in 10-min intervals for 90 min at 37  °C under a 
sealed environment by overlaying with 100 μL of mineral 
oil to limit the exchange of oxygen. Tyrode’s buffer with 
10  μL of MitoXpress-Xtra HS compound was used as a 
reference. Each sample was analysed in duplicate. The 
rate of change in fluorescence signal per minute was cal-
culated for each 10-min interval, and an average signal 
change per minute during the whole 90-min period was 
calculated for each chicken.
Statistical analysis
Data are presented as the mean ± standard error of the 
mean (SEM) (n = 9 for each group). Differences between 
groups were determined using one-way ANOVA with a 
least significant difference (LSD) test. The significance 
level was set at P < 0.05. All calculations were performed 
using STAT GRA PHICS Centurion XVI ver. 16.1.03 
software.
Results
LPS challenge compromised bird growth rate
The average BWG for the period of challenge was lower 
in the LPS groups than in the placebo group (P < 0.001). 
The BWG in challenged chickens fed diets with a basal vE 
level was almost fivefold lower than that in the respective 
placebo group, while the BWG in challenged chickens fed 
a gradually increasing vE level was 2.5-fold lower than 
that in the respective placebo group. ASA supplementa-
tion did not significantly influence bird BWG during the 
challenge (Figure 1).
ASA supplementation increased the concentration of AA 
in the blood
The blood concentration of AA in birds fed basal and 
gradually increasing vE treatments averaged 3.52 and 
3.21  ng/mL, respectively. In both treatments, dietary 
supplementation with ASA resulted in significantly 
increased AA concentrations in chicken blood (P < 0.001; 
Figure 2A).
Gradually increasing level of vE evoked an ASA effect 
during challenge
The concentration of  TBX2 in chicken blood is shown 
in Figure  2B. In chickens fed diets with basal levels of 
vE, the concentration of  TBX2 did not differ, but in 
b
a a
b
a a
0
50
100
150
200
250g,nia
Gthgie
W
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Figure 1 The body weight gain of chickens in each group. LPS—
birds at 32 days of age were intraperitoneally injected at a dose of 
250 μg/kg of body weight with E. coli LPS; ASA—acetylsalicylic acid at 
a dose of 1 g/kg of diet; basal vitamin E (vE) level—80 mg/kg of diet; 
gradually increasing vE level—160 and 240 mg/kg of diet fed in the 
period 8–21 days and 22–35 days, respectively. a,b The different letters 
represent significant differences (P < 0.05). The same letters indicate 
that the differences between the test group and the placebo group 
were not significant (P > 0.05). Error bars represent the mean values of 
standard errors for 9 birds in each dietary treatment.
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the other groups that were fed gradually increasing vE 
treatments, the concentration of  TBX2 was increased in 
birds challenged with LPS and receiving ASA supple-
mentation (P < 0.05).
Enzyme mRNA expression
The mRNA expression of the COX-1, COX-2, LOX-12 
and CYP450 in immune tissues is presented in Figure 3. 
The mRNA expression of the respective enzymes varied 
in different immune tissues. In the spleen, an increased 
level of COX-1 was found in the challenged group fed 
a gradually increasing level of vE, while an increased 
expression of COX-2 occurred in all groups fed a basal 
vE level (P < 0.001). In the bursa of Fabricius, the high-
est expression of COX-1 occurred in the placebo group 
with a basal vE level, and COX-2 expression did not 
differ significantly, whereas the highest expression of 
CYP450 occurred in the LPS-challenged group fed a 
gradually increasing vE level with ASA (P < 0.001). Thy-
mus expression of COX-1 and COX-2 was the highest 
in challenged birds fed a gradually increasing vE level, 
while CYP450 mRNA expression was the highest in the 
placebo group with a basal vE level (P < 0.001). Feed-
ing birds with a gradually increasing level of vE and 
with ASA resulted in LOX-12 mRNA expression in the 
spleen and thymus being lower than that in the placebo 
group (P < 0.001), while in the bursa of Fabricius, the 
mRNA expression of LOX-12 was at the same level in 
all groups apart from the group that was fed a gradu-
ally increasing vE level and treated with LPS + ASA 
(P < 0.001).
ASA counteracted platelet mitochondrial dysfunction 
during LPS challenge
The oxygen consumption rate by the platelet mitochon-
dria, expressed as a change in fluorescence signal in 
time (intensity inversely proportional to the extracellu-
lar oxygen level) is presented in Figure 4. In all groups, 
the fluorescence signal decreased in time. In birds fed 
a basal vE level, the rate of signal decrease was greater 
in the LPS group than in the placebo and LPS + ASA 
groups; in birds fed diets with gradually increasing 
vE levels, the rate of signal decrease was lower in the 
LPS + ASA group than in the LPS group (P < 0.001).
Discussion
Recently, a number of strategies have been investigated 
towards anti-inflammatory effect. Our previous work 
[16] showed that although feeding broilers diets high 
in n-3 fatty acids (FAs) and with an increased vE dose 
clearly limited the availability of AA and consequently 
antagonised lipid peroxidation during mitogen stimu-
lation. This study provides evidence that the specific 
response in challenge conditions in birds is mediated 
by the simultaneous action of different enzymes, which 
produce lipid hormones involved in inflammation. In 
a recent study, we investigated the concept that ASA 
might selectively inhibit COX-1 without blocking other 
enzymes, which could result in the downregulation of 
highly proinflammatory PG formation while promot-
ing the biosynthesis of mediators of anti-inflammatory 
properties. Owing to the prooxidant activity of exces-
sive dietary vE [17], we additionally investigated the 
Figure 2 Blood concentrations of arachidonic acid (AA) (A) and 11-dehydro-thromboxane B2 (TBX2) (B) in chickens of each group. LPS—
birds at 32 days of age were intraperitoneally injected at a dose of 250 μg/kg of body weight with E. coli LPS; ASA—acetylsalicylic acid at a dose of 
1 g/kg of diet; basal vitamin E (vE) level—80 mg/kg of diet; gradually increasing vE level—160 and 240 mg/kg of diet fed in the period 8–21 days 
and 22–35 days, respectively. a,b The different letters represent significant differences (P < 0.05). The same letters indicate that the differences 
between the test group and the placebo group were not significant (P > 0.05). Error bars represent the mean values of standard errors for 9 birds in 
each dietary treatment.
Page 6 of 10Konieczka et al. Vet Res           (2019) 50:65 
potential of a gradually increasing vE dose to support 
ASA actions.
The E. coli endotoxin challenge applied in this study 
was successful at inducing overall inflammation in birds. 
This effect was manifested in the lower BWG in the 
LPS-challenged groups than that in the placebo group. 
Interestingly, we observed a growth depression after the 
challenge period in some cases, indicating a high magni-
tude of inflammation. A similar response was observed in 
other reports [2, 18]; hence, it was found that the admin-
istration of LPS to birds triggered the repartitioning of 
nutrients away from growth maintenance to mediate 
inflammatory processes via the neuroendocrine-immune 
axis. According to Klasing [19], the costs of the immune 
response in birds consist of 9% of the nutrient needs; 
however, constant maintenance of activated cell popula-
tions and production of constitutively expressed inflam-
matory mediators might require much greater costs than 
those required for maintenance [20]. Our results demon-
strated the costs associated with mounting an immune 
response as a result of challenge.
Feeding broilers with a typical commercial diet pro-
vides AA as a dominant substrate for eicosanoid synthe-
sis [9]. An inflammation process triggers the release of 
AA from membrane phospholipids, and via phospholi-
pase  A2, AA becomes available as a substrate for eicos-
anoid formation. Therefore, the total available pool of 
blood AA may have considerable consequences for the 
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Figure 3 The expression of COX-1, COX-2, LOX-12, and CYP450 
mRNA in the spleen, bursa of Fabricius, and thymus tissues of 
chickens. LPS—birds at 32 days of age, for the subsequent 3 days, 
were intraperitoneally injected at a dose of 250 μg/kg of body weight 
with E. coli LPS, acetylsalicylic acid (ASA) at a dose of 1 g/kg of diet, 
and a basal level of vitamin E (vE) at a dose of 80 mg/kg of diet; the 
vE dose was gradually increased to 160/240 mg/kg of diet during the 
periods of 8–21 days and 22–35 days, respectively. a,b,c,d The different 
letters represent significant differences (P < 0.05). The same letters 
indicate that the differences between the test group and the placebo 
group were not significant (P > 0.05). Error bars represent the mean 
values of standard errors for 9 birds in each dietary treatment.
Figure 4 Oxygen consumption rate by platelet mitochondria 
expressed as a rate of fluorescence signal change per minute. 
LPS—birds at 32 days of age, for the subsequent 3 days, were 
intraperitoneally injected at a dose of 250 μg/kg of body weight 
with E. coli LPS, acetylsalicylic acid (ASA) at a dose of 1 g/kg of diet 
and a basal level of vitamin E (vE) at 80 mg/kg diet; the vE dose was 
gradually increased to 160 and 240 mg/kg of diet during the periods 
of 8–21 days and 22–35 days, respectively. a,b,c The different letters 
represent significant differences (P < 0.05). The same letters indicate 
that the differences between the test group and the placebo group 
were not significant (P > 0.05). Error bars represent the mean values of 
standard errors for 9 birds in each dietary treatment.
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inflammatory response pathway. The results of our study 
indicate the regulatory action of ASA in mediating AA 
metabolism. In both challenged groups but not in those 
fed ASA, the blood level of AA was the same as that in 
the placebo group. This result may suggest that during 
LPS challenge, AA conversion into stress mediators was 
maintained at a constant rate while ASA supplementa-
tion inhibited enzymes responsible for AA conversion. 
Thus, an increased level of AA in the ASA-fed groups was 
observed. These findings may indicate that ASA action 
in birds could inhibit stress mediator synthesis. This 
phenomenon might be of particular importance since it 
was shown in mice [21] that inhibition of the enzymatic 
pathway by ASA generated a novel array of bioactive lipid 
mediators, which provides a novel target for therapeutic 
action Figure 5.
Currently, the measurement of blood  TBX2 concentra-
tion is considered the best laboratory approach to study 
aspirin resistance. COX-1 metabolizes AA into throm-
boxane  A2, which in turn, due to a short half-life, is con-
verted into  TBX2 (stable metabolite). ASA functions by 
acetylating and irreversibly inhibiting COX-1, therefore 
inhibiting the production of  TBX2, which might be a 
direct way to analyse aspirin’s resistance. In this context, 
our results showing increased levels of blood  TBX2 in 
challenged birds fed a gradually increasing vE level are 
unexpected. It is known that vE prevents AA oxidation 
[24]; therefore, a higher pool of AA is able to enter the 
eicosanoid pathway during inflammation, which may 
explain the obtained results. The possible mechanism of 
this phenomenon is not clear, but it might be true that the 
biosynthesis of  TBX2 in these birds occurred by pathways 
that are not blocked by aspirin, e.g., by COX‐2 [22]. This 
hypothesis corresponds to our speculation raised above 
that ASA may generate a novel, aspirin-triggered array of 
bioactive stress mediators through a shift in enzymatic 
complex activity. However, an increased level of blood 
 TBX2, but in only challenged birds, seems to exclude the 
gradually increasing level of vE contributing via oxidative 
stress to aspirin resistance [23] since we did not observe 
an increased  TBX2 level in the respective placebo group. 
The fact that vE is known to prevent AA oxidation might 
be significant [24]; therefore, a higher pool of AA is able 
to enter the eicosanoid pathway during inflammation, 
which was also evidenced in the recent study.
Although inflammatory lipid mediators are produced 
mainly by activated macrophages and monocytes as 
a response to stressor stimuli, the contribution of the 
other pathways of their supply in avian species is poorly 
discovered. Indeed, the enzymatic systems of control-
ling the pathways of inflammatory lipid mediator syn-
thesis are active throughout the tissues of the whole 
biological system (reviewed by Panigrahy et  al. [25]). 
Understanding this contribution might be of signifi-
cance and may provide new opportunities to control 
the inflammation process in birds. We showed that var-
iable mRNA expression of COX-1, COX-2, LOX-12, and 
CYP450 in immune tissues, including the spleen, bursa 
of Fabricius and thymus, occurred in birds as a result 
of dietary treatments and LPS challenge. To the best 
of our knowledge, there are no data available regard-
ing such gene expression in the bird immune tissues; 
therefore, we cannot confirm these results with other 
reports. However, our findings indicated that induced 
inflammation affected enzyme mRNA expression in 
bird immune tissues, which was likely triggered via 
the neuroendocrine-immune axis [26]. Of significance 
would be understanding whether such a phenomenon 
occurs similar to that in activated macrophages and 
monocytes or occurs via an independent pathway and 
therefore might be a target for modulation. Because 
the mRNA expression of enzymes was different among 
immune tissues, we could not observe any logical regu-
latory mechanism governing this process. Interestingly, 
we found that the highest mRNA expression of CYP450 
in the bursa of Fabricius occurred in challenged birds 
fed a gradually increasing level of vE and ASA, suggest-
ing a shift in the enzymatic activity towards synthe-
sis of eicosanoids other than PGs, which is mediated 
by COX-1. Chiang et  al. [27] reported that due to the 
activity of CYP450, a series of aspirin-triggered lipox-
ins are generated during the inflammatory response. 
These lipoxins might evoke potent anti-inflammatory 
and pro-resolving actions. More recently, it was shown 
in a different model that ASA acetylated COX-2, which 
led to the inhibition of prostaglandin  E2, one of the 
most proinflammatory eicosanoids [28]; furthermore, 
a novel array of stress mediators was synthesized as 
a response to inflammation [29]. Szczeklik et  al. [30] 
reported that activated COX-2 releases 15-hydrop-
eroxide of eicosatetraenoic acid, which is a potential 
substrate for less-proinflammatory eicosanoid media-
tors, e.g., 15-epi-lipoxins. In line with this finding, our 
study demonstrated increased COX-2 mRNA expres-
sion in the thymus of birds fed a gradually increasing 
vE level, suggesting that vE may play a regulatory role 
in mediating the LPS-induced inflammatory response, 
which corresponds to the findings of another study 
[31]. In the present study, we observed reduced expres-
sion of LOX-12 mRNA in the spleen and thymus. This 
enzyme plays a key role in various inflammatory path-
ways and has the ability to oxidise biomembranes, 
including mitochondrial membranes [32]. According 
to Mabalirajan et  al. [33], LOX can metabolize AA to 
produce different stress mediators, e.g. PGs, and vE can 
also play a role in this phenomenon since it reduced 
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the expression of 12/15-LOX and its metabolites in a 
murine model. Moreover, in the aforementioned study, 
vE administration restored mitochondrial function in 
induced inflammation.
In the present study, an oxygen consumption assay 
was applied to evaluate whether diets with ASA could 
have toxicity impacts in chickens and ASA interacted 
with a gradually increasing level of vE. Dietary vE is 
predominantly mobilized in mitochondrial fractions 
and is a key element responsible for maintaining their 
integrity and functions [34, 35]. Therefore, any imbal-
ance of vE in mitochondrial fractions evokes mitochon-
drion-derived oxidative stress, which consequently 
impairs mitochondrial function [36]. Oxygen consump-
tion assay allows the determination of respiration rates 
for metabolic characterization and the evaluation of 
toxic effects of treatments on mitochondrial function 
[12]. A lower extracellular level of oxygen indicates a 
higher rate of its consumption by the mitochondria. 
Because mitochondria play a key role in metabolic 
processes of the whole biological system, their impair-
ment is a major mechanism of drug-induced toxicity. In 
a recent study, we measured the oxygen consumption 
rate by blood platelet mitochondria as an indicator of 
the effect of a treatment, as it may have an implication 
for further application. Blood-based analyses are an 
easy-to-apply approach and therefore can be used to 
evaluate dietary treatment effects in birds. Our findings 
indicated that LPS-induced inflammation increased 
the rate of fluorescence signal decrease, particularly in 
birds fed diets with a basal vE level, but this effect was 
alleviated by ASA. It must be noted that the fluores-
cence signal from MitoXpress-Xtra HS should increase 
with time. For unknown reasons, the signal decreased 
in all birds with time, which may suggest an oxygen leak 
from blood platelets. Nonetheless, our results indicate 
that dietary ASA supplementation may have a ben-
eficial effect on platelet mitochondria, while dietary 
vE level has no impact on extracellular oxygen con-
sumption. These results correspond to previous result 
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Figure 5 Possible pathways for the synthesis of bioactive stress 
mediators from the arachidonic acid (AA) cascade in the immune 
tissues of chickens. In response to E. coli LPS stimuli, AA is released 
from membrane phospholipids. It is then converted to biologically 
active series of prostaglandins (PGs) including prostaglandin E2 (PGE2), 
by the action of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 
(COX-2) enzymes, which evoke the acute phase of inflammation 
(A). The stress mediator synthesis pathway differs in the presence 
of acetylsalicylic acid (ASA) and vitamin E (vE) (B); COX-1 is inhibited 
while, COX-2 is irreversibly acetylated and switches from producing 
PGs. In such circumstances, AA is metabolized to a greater extent 
by lipoxygenase-12 (LOX-12) and cytochrome P450 (CYP450) 
pathways. This mechanism, in turn, may lead to the generation of 
novel biologically active resolvins via pathways other than those 
mediated by COX-1. The generation of these and related compounds 
represents a novel mechanism for the therapeutic benefits of dietary 
supplementation with ASA and vE, which may be important in 
controlling inflammation in birds.
▸
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showing that LPS challenge compromised bird per-
formance, which suggests that measurement of blood 
platelet function based on the oxygen consumption 
assay reflects the health status of chickens. Thus, our 
findings indicated that oral ASA supplementation did 
not induce toxicity in birds since the level of extracel-
lular oxygen was higher in the LPS + ASA group than 
that in the LPS-challenged group. More specifically, 
we found that blood platelet function in challenged 
birds that were fed a gradually increasing vE level were 
restored after ASA supplementation, while a gradually 
increasing vE level effectively maintained platelet func-
tion since we observed a reduced oxygen metabolism 
efficacy in only LPS-treated birds fed a basal vE level. 
Taken together, these data suggest that neither ASA nor 
vE levels applied in this study exerted toxicity effects. 
Moreover, alleviated mitochondrial dysfunction due to 
ASA and vE administration might be beneficial during 
the initial inflammatory response since it was suggested 
that they play a key function during antigen presenta-
tion [37, 38].
In summary, the results of the present study indicate 
that a complex regulatory system is triggered by E. coli-
induced inflammation to facilitate the stress-mediator 
response in birds. Here, we demonstrated that dur-
ing inflammation, the immune tissue responses at the 
transcriptional level shift in the gene expression of 
enzymatic complexes, generating less-proinflamma-
tory eicosanoids. However, the contribution of these 
pathways to the whole immune response to challenge 
remains unknown. Our results suggest that ASA plays 
a regulatory role in stress mediation by increasing the 
total pool of AA entering eicosanoid pathways and by 
inhibiting COX-1 expression. The results also suggest 
that neither ASA nor vE manifested a toxicity effect 
on platelet mitochondria but feeding birds a gradually 
increasing level of vE might be associated with ASA 
resistance during challenge. These findings will likely be 
beneficial in developing targeted control strategies and/
or for monitoring treatment effects.
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